Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden
- PMID: 17139368
Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden
Abstract
The factor V Leiden (FVL) mutation, a genetic abnormality with an autosomal mode of inheritance, is associated with an increased risk of venous thromboembolism (VTE). We aimed to determine the annual incidence of VTE in first-degree relatives of patients with VTE and FVL and to identify factors in patients and the relatives that influence this incidence. In this retrospective and prospective cohort study, the incidence of objectively diagnosed first episodes of VTE was assessed in 553 first-degree relatives of 161 patients with acute VTE and FVL. The annual incidence of VTE was 0.43% (95% CI, 0.3 to 0.56) with FVL and 0.17% (95% CI, 0.07 to 0.27) without FVL (relative risk of 2.5,95% CI, 1.3 to 4.7). A majority (70%) of episodes of VTE were provoked, and this proportion was similar with and without FVL. A larger proportion of VTE was provoked in women (83%) that in men (33%), with the difference accounted for by pregnancy and use of oral contraceptives. The proportion of pregnancies complicated by VTE was 3.9% (95% CI, 2.0-5.8) with FVL and 1.4% (95% CI, 0.04-2.7) without FVL. FVL is associated with a two- to threefold increase in VTE in first-degree relatives of patients with VTE. No subgroup of relatives was identified who require more than routine prophylaxis because of a particularly high risk of VTE.
Similar articles
-
Venous thrombotic risk in family members of unselected individuals with factor V Leiden.Thromb Haemost. 2000 Jun;83(6):817-21. Thromb Haemost. 2000. PMID: 10896231
-
High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.Thromb Haemost. 2007 Feb;97(2):171-5. Thromb Haemost. 2007. PMID: 17264942
-
[The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results].Dtsch Med Wochenschr. 2000 Jan 7;125(1-2):2-6. doi: 10.1055/s-2007-1023875. Dtsch Med Wochenschr. 2000. PMID: 10650817 German.
-
Sex and gender issues and venous thromboembolism.Clin Chest Med. 2004 Jun;25(2):281-97. doi: 10.1016/j.ccm.2004.01.013. Clin Chest Med. 2004. PMID: 15099889 Review.
-
Epidemiology of venous thromboembolism.Semin Vasc Med. 2001;1(1):7-26. doi: 10.1055/s-2001-14668. Semin Vasc Med. 2001. PMID: 15199510 Review.
Cited by
-
Usefulness of factor V Leiden mutation testing in clinical practice.Eur J Hum Genet. 2010 Aug;18(8):862-6. doi: 10.1038/ejhg.2010.33. Epub 2010 Mar 24. Eur J Hum Genet. 2010. PMID: 20332812 Free PMC article.
-
An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women's Genome Health Study.Circ Cardiovasc Genet. 2009 Feb;2(1):57-62. doi: 10.1161/CIRCGENETICS.108.801969. Epub 2009 Jan 23. Circ Cardiovasc Genet. 2009. PMID: 20031567 Free PMC article.
-
Factors that predict thrombosis in relatives of patients with venous thromboembolism.Blood. 2014 Sep 25;124(13):2124-30. doi: 10.1182/blood-2014-03-559757. Epub 2014 Jul 21. Blood. 2014. PMID: 25049279 Free PMC article.
-
Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.Semin Thromb Hemost. 2016 Nov;42(8):808-820. doi: 10.1055/s-0036-1592333. Epub 2016 Oct 20. Semin Thromb Hemost. 2016. PMID: 27764878 Free PMC article. Review.
-
Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.Thromb Haemost. 2016 Sep 27;116(4):705-13. doi: 10.1160/TH16-02-0172. Epub 2016 Jun 16. Thromb Haemost. 2016. PMID: 27305932 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical